Inozyme Pharma, a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization, entered into a debt financing facility for up to $70 million with K2 HealthVentures (K2HV), a...
view press release
July 27, 2022, 08:00 AM
|
Corbus Pharmaceuticals Holdings, a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, announced it has received an aggregate of $71 million in gross proceeds from its at-the-market...
view press release
July 30, 2020, 08:10 AM
|